High-dose chemotherapy and autologous peripheral blood stem cell transplantation for treatment of unspecified peripheral T-cell lymphoma presented with hepatosplenomegaly and hypercytokinemia syndrome: Report of three cases

Annals of Hematology

Volumn 81, Issue 10, 2002, Pages 588-592

  Tsuchiyama, J ^a   Imajo, K ^a   Yoshino, T ^b   Nanba, N ^a   Toyota, A ^a   Yoshida, C ^a   Fujii, K ^a   Kondo, E ^a   Okazuka, K ^c   Hashimoto, S ^c   Toba, K ^c   Fuse, I ^c   Aizawa, Y ^c   Harada, M ^b   Tsubota, T ^a  

^a Okayama Citizens Hospital   (Japan)

^b OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

^c NIIGATA UNIVERSITY   (Japan)

Author keywords

Autologous peripheral blood stem cell transplantation; Hypercytokinemia; Peripheral T cell lymphoma unspecified

Indexed keywords

ANTINEOPLASTIC AGENT; BETA 2 MICROGLOBULIN; CARBOPLATIN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYTOKINE; DOXORUBICIN; ETOPOSIDE; FERRITIN; IFOSFAMIDE; INTERLEUKIN 2 RECEPTOR; MITOXANTRONE; PREDNISOLONE; PREDNISONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; VINCRISTINE;

ADULT; AGED; ANASARCA; ARTICLE; ASTHMA; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BONE MARROW SUPPRESSION; CANCER CLASSIFICATION; CANCER INFILTRATION; CANCER REGRESSION; CANCER RISK; CASE REPORT; CEREBROVASCULAR DISEASE; CLINICAL FEATURE; CYTOPENIA; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG MEGADOSE; ERYTHROPHAGOCYTOSIS; FEMALE; FEVER; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEPATOSPLENOMEGALY; HIGH RISK PATIENT; HISTOLOGY; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROGNOSIS; T CELL LYMPHOMA;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CYTOKINES; FEMALE; GENE REARRANGEMENT; GENES, T-CELL RECEPTOR BETA; HEPATOMEGALY; HUMANS; LYMPHOMA, T-CELL, PERIPHERAL; MALE; MIDDLE AGED; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; SPLENOMEGALY; TRANSPLANTATION, AUTOLOGOUS;

EID: 0036946611     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-002-0526-8     Document Type: Article

References (30)

1. Ansell SM, Habermann TM, Kurtin PJ, Witzig TE, Chen MG, Li CY, Inwards DJ, Colgan JP (1997) Predictive capacity of the International Prognostic Factor Index in patients with peripheral T-cell lymphoma. J Clin Oncol 15:2296-2301
2. Blystad AK, Enblad G, Kvaloy S, Berglund A, Delabie J, Holte H, Carlson K, Kvalheim G, Bengtsson M, Hagberg H (2001) High-dose therapy with autologous stem cell transplantation in patients with peripheral T cell lymphomas. Bone Marrow Transplant 27:711-716
3. Coffier B, Brousse N, Peuchmaur M, Berger F, Gisselbrecht C, Bryon PA, Diebold J, for the GELA (1990) Peripheral T-cell lymphomas have a worse prognosis than B-cell lymphomas: a prospective study of 361 immunophenotyped patients treated with the LNH84 regimen. Ann Oncol 1:45
4. Elias AD, Ayash LJ, Wheeler C, Schwartz G, Tepler I, McCauley M, Mazanet R, Schniper L, Frei E 3rd, Amman KH (1994) High-dose ifosfamide/carboplatin/etoposide with autologous hematopoietic stem cell support: safety and future directions. Semin Oncol 21:83-85
5. Fujiwara F, Hibi S, Imashuku S (1993) Hypercytokinemia in hemophagocytic syndrome. Am J Pediatr Hematol Oncol 15:92-98
6. Gianni AM, Bregni M, Siena S, Brambilla C, Nicola M, Lombardi F, Gandola. F, Tarella C, Pileri A, Ravagnani F, Valagussa P, Bonnadonna G (1997) High-dose chemotherapy and autologous bone marrow transplantation compared with MACOP-B in aggressive B cell lymphoma. N Engl J Med 336:1290-1297
7. Gisselbrecht C, Gaulard P, Lepage E, Coiffier B, Briere J, Haioun C, Cazalas-Hatem D, Bosly A, Xerri L, Tilly H, Berger F, Bouhabdallah R, Diebold J (1998) Prognostic significance of T cell phenotype in aggressive non-Hodgkin's lymphoma. Blood 92:76-82
8. Greer JP, York JC, Cousar JB, Mitchell RT, Flexner JM, Collins RD, Stein RS (1984) Peripheral T cell lymphoma: a clinicopathologic study of 42 cases. J Clin Oncol 2:788
9. Haioun C, Lepage E, Gisselbrecht C, Salles G, Coiffier B, Brice P, Bosly A, Morel P, Nouvel C, Tilly H, Lederlin P, Sebban C, Briere J, Gaulard P, Reyes F (2000) Survival benefit of high-dose therapy in poor-risk aggressive non-Hodgkin's lymphoma: final analysis of the prospective LNH87-2 protocol-A Groupe d'Etude des Lymphoma de l'Adulte Study. J Clin Oncol 18:3025-3030
10. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JKC, Cleary ML, Delsol G, De Wolf-Peters C, Falini B, Gatter KC, Grogan TM, Isaacson PG, Knowles DM, Mason DY, Muller-Hermlink H, Pileri SA, Piris MA, Ralfkiaer E, Warnke RA (1994) A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 84:1361
11. Ho JW, Liang RH, Srivastava G (1999) Peripheral type 1-1 cytokine gene expression in peripheral T-cell lymphomas. Hematol Oncol 17:117-129
12. Ho JW, Liang RH, Srivastava G (1999) Differential cytokine expression in EBV positive peripheral T cell lymphoma. Mol Pathol 52:269-274
13. Imashuku S (2000) Advances in the management of hemophagocytic lymph histiocytosis. Int J Hematol 72:1-11
14. Jillella AP, Day DS, Severson K, Kallab AM, Burgess R (2000) Non-Hodgkin's lymphoma presenting as anasarca: probably mediated by tumor necrosis factor alpha (TNF-alpha). Leuk Lymphoma 38:419-422
15. Lopez-Guillermo A, Cid J, Salar A, Lopez A, Montalban C, Castrillo JM, Gonzalez M, Ribera JM, Brunet S, Garcia-Conde J, Fernandez de Sevilla A, Bosch F, Montserrato E (1998) Peripheral T cell lymphomas: initial features, natural history, and prognostic factors in a series of 174 patients diagnosesd according to the REAL classification. Ann Oncol 9:849-855
16. Macon WR, Levy NB, Kurtin PJ, Salhany KE, Elkhalifa MY, Casey TT, Craig FE, Vnencak-Jones CL, Gulley ML, Park JP, Cousar JB (2001) Hepatosplenic alpha beta T-cell lymphomas: a report of 14 cases and comparison with hepatosplenic gamma delta T-cell lymphomas. Am J Surg Pathol 25:285-296
17. Melnyk A, Rodriguez A, Cabannillas F (1997) Evaluation of the revised European-American Lymphoma classification confirms the clinical relevance of immunophenotype in 560 cases of aggressive non-Hodgkin's lymphoma. Blood 89:4514-4520
18. Miyahara M, Sano M, Shibata K, Matsuzaki M, Ibaraki K, Shimamoto Y, Tokunaga O (2000) B-cell lymphoma-associated hemophagocytic syndrome: clinicopathological characteristics. Ann Hematol 79:378-388
19. Nakamura S, Suchi T, Koshikawa T, Suzuki H, Oyama A, Kojima. M, Motoori T, Ueda R, Takahashi T (1993) Clinicopathologic study of 212 cases of peripheral T-cell lymphoma. among the Japanese. Cancer 72:1762-1772
20. Ohga S, Matsuzaki A, Nishizaki M, Nagashima T, Kai T, Suda M, Ueda K (1993) Inflammatory cytokines in virus-associated hemophagocytic syndrome. Interferon-gamma as a sensitive indicator of disease activity. Am J Pediatr Hematol Oncol 15:291-298
21. Ohshima K, Haraoka S, Suzumiya J, Kawasaki J, Kanda M, Kikuchi M (2000) Cytoplasmic cytokines in lymphoproliferative disorders: multiple cytokine production in angioimmunoblastic lymphadenopathy with dysproteinemia. Leuk Lymphoma 38:541-545
22. Omagari K, Ashida R, Oh-I H, Minamino Y, Sasaki O, Ozono Y, Maeda T, Sadamori N, Tomonaga M, Kohno S (1997) Successful treatment with cyclosporine in a case of hemophagocytic syndrome manifesting as severe liver dysfunction. Am J Med Sci 314:403-407
23. Rodriguez J, Munsell M, Yazji S, Hagemeister FB, Younes A Andersson B, Giralt S, Gajewski J, de Lima M, Couriel D, Romaguera J, Cabanillas FF, Champlin RE, Khouri IF (2001) Impact of high-dose chemotherapy on peripheral T cell lymphomas. J Clin Oncol 19:3766-3770
24. Shimoyama M, Oyama A, Tajima K, Tobinai K, Minato K, Takenaka T, Konda C, Takeyama K, Kohno A, Narabayashi M (1993) Differences in clinicopathological characteristics and major prognostic factors between B-lymphoma and peripheral T-lymphoma excluding adult T-cell leukemia/lymphoma. Leuk Lymphoma. 10:335-342
25. Suarez F, Wlodarska I, Rigal-Huguet F, Mempel M, Martin-Garcia N, Farcet JP, Delsol G, Gaulard P (2000) Hepatosplenic alpha beta T-cell lymphoma: an unusual case with clinical, histologic, and cytogenetic features of gamma delta hepatosplenic T-cell lymphoma. Am J Surg Pathol 24:1027-1032
26. The non-Hodgkin's lymphoma classification project (1997) A clinical evaluation of the International Lymphoma Study Group Classification of non-Hodgkin's lymphoma. Blood 89:3909
27. Tsuchiyama J, Imajo K, Sakaguchi N, Yoshino T, Suzuki N, Kondo E, Kawata N, Okada K, Maeda T, Tomiyama Y, Tsubota T (2000) Recurrent idiopathic iridocyclitis after autologous peripheral blood stem-cell transplantation followed by G-CSF administration for acute lymphoblastic leukemia. Ann Hematol 79:269-271
28. Tsuchiyama J, Yoshino T, Imajo K, Kondou E, Hamada E, Tomiyama Y, Toba K, Furukawa T, Fuse I, Aizawa Y, Harada M, Tsubota T Lymphomatous polyp of mantle cell type in duodenum complicated by gastric cancer: a case of trisomy 3 and t(11;14)(q13;q32). Ann Hematol 2002 (in press)
29. Uno M, Tsuchiyama J, Moriwaki A, Noguchi T, Mizoguchi K, Ogino T, Yoshino T, Okada S, Harada M (2001) In vitro induction of apoptosis for nasal angiocentric NK cell lymphoma- derived cell line, NK-YS, by etoposide and cyclosporine A. Br J Hematol 113:1009-1014
30. Vose JM (1996) Dose-intensive ifosfamide for the treatment of non-Hodgkin's lymphoma. Semin Oncol 23:33-37